Allergan   1Q Revenue: $3.8 billion (+48%) 1Q Earnings: $256.4 million (loss of $512.3 million in 1Q15) Comments: Global branded product revenues were $3.4 billion, up 70% driven by Botox, Restasis, and Fillers. Botox revenues in the quarter were $638 million, driven by continued strong performance in both aesthetic and therapeutic indications. Restasis revenues were $314 million, driven by strong promotional efforts. Fillers’ revenues were $215 million with continued strong perfor...